-->
1. SERVICE OVERVIEW
1.1. MARKET DEFINITION
1.2. SCOPE OF THE MARKET
1.2.1. MARKETS COVERED
1.2.2. YEARS CONSIDERED FOR STUDY
1.2.3. KEY MARKET SEGMENTATIONS
2. RESEARCH METHODOLOGY
2.1. OBJECTIVE OF THE STUDY
2.2. BASELINE METHODOLOGY
2.3. KEY INDUSTRY PARTNERS
2.4. MAJOR ASSOCIATION AND SECONDARY SOURCES
2.5. FORECASTING METHODOLOGY
2.6. DATA TRIANGULATION & VALIDATIONS
2.7. ASSUMPTIONS AND LIMITATIONS
3. EXECUTIVE SUMMARY
3.1. OVERVIEW OF THE MARKET
3.2. OVERVIEW OF KEY MARKET SEGMENTATIONS
3.3. OVERVIEW OF KEY MARKET PLAYERS
3.4. OVERVIEW OF KEY REGIONS/COUNTRIES
3.5. OVERVIEW OF MARKET DRIVERS, CHALLENGES, TRENDS
4. VOICE OF CUSTOMER
5. JAPAN CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET OUTLOOK
5.1. MARKET SIZE & FORECAST
5.1.1. BY VALUE
5.2. MARKET SHARE & FORECAST
5.2.1. BY PRODUCT (API, DRUG PRODUCT)
5.2.2. BY WORKFLOW (CLINICAL, COMMERCIAL)
5.2.3. BY APPLICATION (ONCOLOGY, HORMONAL, GLAUCOMA, CARDIOVASCULAR DISEASE, DIABETES, OTHERS)
5.2.4. BY REGION
5.2.5. BY COMPANY (2024)
5.3. MARKET MAP
6. CHUBU CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET OUTLOOK
6.1. MARKET SIZE & FORECAST
6.1.1. BY VALUE
6.2. MARKET SHARE & FORECAST
6.2.1. BY PRODUCT
6.2.2. BY WORKFLOW
6.2.3. BY APPLICATION
7. KYUSHU CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET OUTLOOK
7.1. MARKET SIZE & FORECAST
7.1.1. BY VALUE
7.2. MARKET SHARE & FORECAST
7.2.1. BY PRODUCT
7.2.2. BY WORKFLOW
7.2.3. BY APPLICATION
8. CHUGOKU CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET OUTLOOK
8.1. MARKET SIZE & FORECAST
8.1.1. BY VALUE
8.2. MARKET SHARE & FORECAST
8.2.1. BY PRODUCT
8.2.2. BY WORKFLOW
8.2.3. BY APPLICATION
9. MARKET DYNAMICS
9.1. DRIVERS
9.2. CHALLENGES
10. MARKET TRENDS & DEVELOPMENTS
10.1. RECENT DEVELOPMENT
10.2. MERGERS & ACQUISITIONS
10.3. PRODUCT LAUNCHES
11. JAPAN CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET: SWOT ANALYSIS
12. PORTER’S FIVE FORCES ANALYSIS
12.1. COMPETITION IN THE INDUSTRY
12.2. POTENTIAL OF NEW ENTRANTS
12.3. POWER OF SUPPLIERS
12.4. POWER OF CUSTOMERS
12.5. THREAT OF SUBSTITUTE PRODUCTS
13. COMPETITIVE LANDSCAPE
13.1. CORDEN PHARMA INTERNATIONAL (JAPAN)
13.1.1. SERVICE OVERVIEW
13.1.2. PRODUCT OFFERINGS
13.1.3. RECENT DEVELOPMENTS
13.1.4. KEY PERSONNEL
13.1.5. SWOT ANALYSIS
13.2. WUXI APPTEC INC
13.3. CAMBREX CORP
13.4. RECIPHARM AB
13.5. LONZA GROUP AG
13.6. CATALENT INC
13.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
13.8. THERMO FISHER SCIENTIFIC INC
13.9. SAMSUNG BIOLOGICS CO LTD
13.10. FUJIFILM CORP
14. STRATEGIC RECOMMENDATIONS
15. ABOUT US & DISCLAIMER
著作権 ©2022 無断複写・転載を禁じます